Synthesis AI
United States
- San Francisco, California
- 28/04/2022
- Series A
- $17,000,000
Pioneering synthetic data technology to build more capable and ethical AI.
- Industry Software Development
- Website https://synthesis.ai/
- LinkedIn https://www.linkedin.com/company/synthesis-ai/
Related People
Yashar BehzadiFounder
United States -
San Francisco Bay Area
Proven executive, experienced technologist, and meticulous product lead with a history of delivering first-in-class products to market.
Specialties:
- Early venture strategy and financing
- Developing novel technologies
- New product introduction and market development across industries
- Building strong teams
- Leading complex and multifaceted product development programs
- Structuring and leading strategic partnerships with large companies
Highlights:
- Launched world's first digital medicines product system (ingestible sensor+pharmaceuticals+wearables+apps)
- Developed first AI-based diagnostic test for broad-spectrum mental illness based on a panel of biomarkers
- 8 years of experience building best-in-class wearables (FDA-approved, CE-marked)
- Pioneered synthetic data technologies for building more capable AI models
- 30+ patents across hardware & software (https://patents.justia.com/inventor/yashar-behzadi)
NavigateAI | $25,000,000 | (May 27, 2026)
The Path | $14,300,000 | (May 27, 2026)
Quartermaster | $43,000,000 | (May 27, 2026)
Qurie GmbH | $2,560,151 | (May 27, 2026)
Clouted | $7,000,000 | (May 27, 2026)
ClearOps | $10,009,454 | (May 27, 2026)
Go Swag | $5,000,000 | (May 27, 2026)
Hardline | $2,000,000 | (May 27, 2026)
Squid | $6,000,000 | (May 27, 2026)
OpenRouter | $113,000,000 | (May 27, 2026)
Hark(1) | $700,000,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)